Sign in

CIK 0001638097

  • Non-accelerated filer
  • Smaller reporting company

Entera Bio Ltd.

Sign in to watch
Ticker
ENTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 25327151
Business address
KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
  1. 4 Open-market buy Director bought 18,000 shares at $1.24 ($22,320)
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Director acquired 28,721 shares (grant or award)
  5. 4 Grant or award Director acquired 25,371 shares (grant or award)
  6. 4 Grant or award Director acquired 30,157 shares (grant or award)
  7. 4 Grant or award Director acquired 38,294 shares (grant or award)
  8. 4 Grant or award Director acquired 26,329 shares (grant or award)
  9. 4 Open-market buy Chief Executive Officer bought 11,000 shares at $1.81 ($19,912)
  10. 4 Grant or award Chief Executive Officer acquired 180,702 shares (grant or award)
  11. 4 Grant or award Chief of R&D acquired 26,316 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 26,316 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award Chief Operating Officer acquired 26,316 shares (grant or award)
  15. 4 Option exercise Director acquired 23,952 shares (option exercise)
  16. 4 Grant or award Director acquired 6,922 shares (grant or award)
  17. 4 Grant or award Director acquired 8,038 shares (grant or award)
  18. 4 Grant or award Director acquired 8,216 shares (grant or award)
  19. 4 Grant or award Director acquired 10,717 shares (grant or award)
  20. 4 Grant or award Director acquired 7,100 shares (grant or award)

Page 2 of 7 · 126 filings